STD Symptoms, STD Pictures, STD Treatment

Experts gathered at a joint meeting of UNAIDS and the WHO last week called for two additional clinical trials to test the effectiveness and safety of a microbicide vaginal gel containing the antiretroviral tenofovir, which previous studies have shown reduces the risk of HIV transmission in women who used it before and after sex by 39 percent, PANA/Afrique en ligne reports (9/5)...

Donors have not committed enough money to move forward with two studies needed to confirm the efficacy of a vaginal microbicidal gel infused with the antiviral drug tenofovir to prevent HIV transmission in women, the New York Times reports...

Risky sexual behavior among members of a subset of the gay community is still adding to the spread of HIV. Research published in the open access journal BMC Infectious Diseases has found that young white homosexual men have an important contribution in the local spread of HIV...

Two further clinical trials are planned to confirm a vaginal gel which has shown potential in reducing the risk of HIV. The results of the first trial of the gel, which were announced in July at the XVIII International AIDS Conference in Vienna, must be confirmed before the product can be made available for general use...

AVAC issues a call to action to donors, policy-makers, researchers and advocates to ensure that critical follow-up studies to the landmark CAPRISA 004 microbicide trial receive the economic and political support needed to move forward as quickly as possible...